NDC 71335-9632-01 - Liothyronine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-9632
- Requested NDC
- 71335-9632-01
- Package NDCs from labels
- 71335-9632-1, 71335-9632-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2023-11-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Liothyronine Sodium - Bryant Ranch Prepack | Bryant Ranch Prepack | 2023-11-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-9632-1 | Liothyronine Sodium | 30 in 1 BOTTLE | TABLET | 30 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-9632 | LIOTHYRONINE SODIUM TABLET [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20231109_20cbf84d-80f2-4b94-ad47-6aaa362fb4d0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Mylan Pharmaceuticals Inc. | 115a84c2-0126-4dd7-816e-1873875f1e49 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Preferred Pharmaceuticals Inc. | 57744c7c-af44-4bc4-a5a8-79f05710f469 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 GCA9VV7D2N |
| Cytomel | LIOTHYRONINE SODIUM | Pfizer Laboratories Div Pfizer Inc | 51452b31-ff68-4e0c-b982-c15502ebf1d3 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | ASCLEMED USA INC. | 26cf6872-f4d4-41dd-8957-a000f13efbb3 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 903697 903703 GCA9VV7D2N |
| Liomny | LIOTHYRONINE SODIUM | SIGMAPHARM LABORATORIES, LLC | 0dcec611-2b7a-4cf3-80c3-7389be2f0a94 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 903697 903703 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 76fa4eb6-fefa-4e97-9543-f81e465743e6 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903697 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Golden State Medical Supply, Inc. | ababc2ad-0458-663e-e053-2a95a90a5a86 | 2025-08-06 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| liothyronine sodium | LIOTHYRONINE SODIUM | A-S Medication Solutions | 1d6b6f92-89e8-497a-ab23-d0afa2137d1f | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 903456 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Bryant Ranch Prepack | b18e24fd-def0-4ff4-aa08-5f91c03c6f9e | 2024-09-06 | Boxed warning, Warnings, Adverse reactions | 903456 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Bryant Ranch Prepack | 5222f13d-7222-4845-b863-49e7558f5b1a | 2024-09-06 | Boxed warning, Warnings, Adverse reactions | 903697 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Zydus Pharmaceuticals (USA) Inc. | c54cf95f-6465-4203-b98b-a54ba5a26843 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Northstar Rx LLC | c97dc9ec-af73-4836-aa0d-c27e66e792a9 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Bryant Ranch Prepack | 9d3633e3-44b7-4f62-9fe4-e5c7c4129345 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 903703 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Biocon Pharma Inc. | 21002702-422b-1402-73b8-670314d8e579 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Dr. Reddy's Labratories Inc. | 0b0f2db9-642d-d84f-b102-b43de34bbe75 | 2024-03-15 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | NuCare Pharmaceuticals,Inc. | 1133ebe8-38c2-2505-e063-6294a90aaa2f | 2024-02-12 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | A-S Medication Solutions | db65bcd8-e9c9-4095-9975-03be1f443823 | 2024-01-26 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | Zydus Lifesciences Limited | 4fb09346-3d30-4a7c-a97c-480d5924997a | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Liothyronine sodium | LIOTHYRONINE SODIUM | A-S Medication Solutions | 52baac91-4b00-40d4-9ca7-8b9405bd415c | 2023-12-09 | Boxed warning, Warnings, Adverse reactions | 903456 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | XGen Pharmaceuticals DJB, Inc. | a8b39730-de19-497d-bde8-6594aa528403 | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | GCA9VV7D2N |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.